By: Tiantian Zhang1, Yiqun Han2, Lei Deng3 1. Department of Internal Medicine, University of Central Florida, Pensacola, FL 2. Mayo Clinic, Rochester, MN 3. University of Washington/Fred Hutch Cancer Center, Seattle, WA
MoreBy: Tiantian Zhang1, Yiqun Han2, Lei Deng3 1. Department of Internal Medicine, University of Central Florida, Pensacola, FL 2. Mayo Clinic, Rochester, MN 3. University of Washington/Fred Hutch Cancer Center, Seattle, WA
MoreBy: Zhiting Tang1, Lei Deng2 1. Unity Hospital, Rochester Regional Health, Rochester, NY2. University of Washington/Fred Hutch Cancer Center, Seattle, WA LAURA: A randomized, double-blind, Phase III study of chemoradiation followed
MoreSEATTLE, WA – The Binaytara Foundation, a non-profit organization dedicated to improving healthcare in underserved communities, is proud to announce the 2023 Summit on Cancer Health Disparities (SCHD), which will take place
MoreThe Binaytara Foundation organized three in-person oncology conferences in October 2021. The 2021 Updates in Hematologic Malignancies and the 2021 Precision Oncology Summit were held in Salt Lake City, Utah on October
More